Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
IRIS
Aims: Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries. Methods and results: Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140mmHg or diastolic BP ≥ 90 mmHg) hypertension. Conclusion: May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk.
May measurement month 2018: A pragmatic global screening campaign to raise awareness of blood pressure by the international society of hypertension
Beaney T.;Burrell L. M.;Castillo R. R.;Charchar F. J.;Cro S.;Damasceno A.;Kruger R.;Nilsson P. M.;Prabhakaran D.;Ramirez A. J.;Schlaich M. P.;Schutte A. E.;Tomaszewski M.;Touyz R.;Wang J. -G.;Weber M. A.;Poulter N. R.;Burazeri G.;Qirjako G.;Roshi E.;Cunashi R.;Fernandes M. J. C. C.;Pereira S. S. V.;Neto M. F. M. P.;Oliveira P. N. M.;Feijao A. C. G.;Cerniello Y.;Marin M. J.;Vasquez F. G.;Espeche W. G.;Stisman D.;Fuentes I. A.;Zilberman J. M.;Rodriguez P.;Babinyan K. Y.;Engibaryan A. H.;Avagyan A. M.;Minasyan A. A.;Gevorkyan A. T.;Carnagarin R.;Carrington M. J.;Sharman J. E.;Lee R.;Perl S.;Niederl E.;Malik F. -T. -N.;Choudhury S. R.;Al Mamun M. A.;Ishraquzzaman M.;Anthony F.;Connell K.;De Backer T. L. M.;Krzesinski J.;Houenassi M. D.;Houehanou C. Y.;Sokolovic S.;Bahtijarevic R.;Tiro M. B.;Mosepele M.;Masupe T. K.;Barroso W. S.;Gomes M. A. M.;Feitosa A. D. M.;Brandao A. A.;Miranda R. D.;Azevedo V. M. A. A.;Dias L. M.;Garcia G. D. N.;Martins I. P. P.;Dzudie A.;Kingue S.;Djomou F. A. N.;Njume E.;Khan N.;Lanas F. T.;Garcia M. S.;Paccot M. F.;Torres P. I.;Li Y.;Liu M.;Xu L.;Li L.;Chen X.;Deng J.;Zhao W.;Fu L.;Zhou Y.;Lopez-Jaramillo P.;Otero J.;Camacho P. A.;Accini J. L.;Sanchez G.;Arcos E.;Buyamba-Kabangu J. -R. M.;Katamba F. K.;Ngoyi G. N.;Buila N. M.;Bayauli P. M.;Mbolla B. F. E.;Bakekolo P. R.;Landa C. M. K.;Kaky G. S. K.;Kramoh E. K.;Ngoran Y. N. K.;Olsen M. H.;Valoy L. V.;Santillan M.;Medina A. R. G.;Penaherrera C. E.;Villalba J.;Ramirez M. I.;Arteaga F.;Delgado P.;Beistline H.;Cappuccio F. P.;Keitley J.;Tay T.;Goshu D. Y.;Kassie D. M.;Gebru S. A.;Pathak A.;Denolle T.;Tsinamdzgvrishvili B.;Trapaidze D.;Sturua L.;Abesadze T.;Grdzelidze N.;Grabfelder M.;Kramer B. K.;Schmeider R. E.;Twumasi-Ankrah B.;Tannor E. K.;Lincoln M. D.;Deku E. M.;Wyss Quintana F. S.;Kenerson J.;Baptiste E. D. J.;Saintilmond W. W.;Barrientos A. L.;Peiger B.;Lagos A. R.;Forgas M. A.;Lee V. W. Y.;Tomlinson B. W. Y.;Jarai Z.;Pall D.;More A.;Maheshwari A.;Verma N.;Sharma M.;Mukherjee T. K.;Patil M.;Jose A. P.;More A.;Takalkar A.;Turana Y.;Widyantoro B.;Danny S. S.;Djono S.;Handari S. D.;Tambunan M.;Tiksnadi B. B.;Hermiawaty E.;Tavassoli E.;Zolfaghari M.;Dolan E.;O'Brien E.;Borghi C.;Ferri C.;Torlasco C.;Parati G.;Nwokocha C. R.;Nwokocha M. I.;Ogola E. N.;Gitura B. M.;Barasa A. L.;Barasa F. A.;Wairagu A. W.;Nalwa W. Z.;Najem R. N.;Alfa A. K. A.;Fageh H. A.;Msalam O. M.;Derbi H. A.;Bettamar K. A.;Zakauskiene U.;Vickiene A.;Calmes J.;Alkerwi A.;Gantenbein M.;Ndhlovu H. L. L.;Masiye J. K.;Chirwa M. L.;Nyirenda N. M.;Dhlamini T. D.;Chia Y. C.;Ching S. M.;Devaraj N. K.;Ouane N.;Fane T.;Kowlessur S.;Ori B.;Heecharan J.;Alcocer L.;Chavez A.;Ruiz G.;Espinosa C.;Gomez-Alvarez E.;Neupane D.;Bhattarai H.;Ranabhat K.;Adhikari T. B.;Koirala S.;Toure I. A.;Soumana K. H.;Wahab K. W.;Omotoso A. B.;Sani M. U.;Okubadejo N. U.;Nadar S. K.;Al-Riyami H. A.;Ishaq M.;Memon F.;Sidique S.;Choudhry H. A.;Khan R. A.;Ayala M.;Maidana A. J. O.;Bogado G. G. G.;Ona D. I.;Atilano A.;Granada C.;Bartolome R.;Manese L.;Mina A.;Dumlao M. C.;Villaruel M. C.;Gomez L.;Jozwiak J.;Malyszko J.;Banach M.;Mastej M.;de Carvalho Rodrigues M. M.;Martins L. L.;Paval A.;Dorobantu M.;Konradi A. O.;Chazova I. E.;Rotar O.;Spoares M. C.;Viegas D.;Almustafa B. A.;Alshurafa S. A.;Brady A.;Bovet P.;Viswanathan B.;Oladapo O. O.;Russell J. W.;Brguljan-Hitij J.;Bozic N.;Knez J.;Dolenc P.;Hassan M. M.;Woodiwiss A. J.;Myburgh C.;Vally M.;Ruilope L. M.;Molinero A.;Rodilla E.;Gijon-Conde T.;Beheiry H. M.;Ali I. A.;Osman A. A. A.;fahal N. A. W.;Osman H. A.;Altahir F.;Persson M.;Wuerzner G.;Burkard T.;Wang T. -D.;Lin H. -J.;Pan H. -Y.;Chen W. -J.;Lin E.;Mondo C. K.;Ingabire P. M.;Khomazyuk T. T. A.;Krotova V. V. -Y.;Negresku E.;Evstigneeva O.;Bazargani N. N. B.;Agrawal A.;Bin Belaila B. A.;Suhail A. M.;Muhammed K. O.;Shuri H. H.;Wainford R. D.;Levy P. D.;Boggia J. J. G.;Garre L. L.;Hernandez-Hernandez R.;Octavio-Seijas J. A.;Lopez-Rivera J. A.;Morr I.;Duin A.;Huynh M. V.;Cao S. T.;Nguyen V. L.;To M.;Phan H. N.;Cockroft J.;McDonnell B.;Goma F. M.;Syatalimi C.;Chifamba J.;Gwini R.;Xia X.;Tiburcio O. V.
2019-01-01
Abstract
Aims: Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries. Methods and results: Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140mmHg or diastolic BP ≥ 90 mmHg) hypertension. Conclusion: May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11697/214174
Citazioni
ND
186
147
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.